Stock-Based Compensation: The estimated market value of stock options, warrants and other stock-based compensation given to employees and/or vendors.
Sonnet BioTherapeutics Holdings, Inc. (SONN) had Stock-Based Compensation of $0.06M for the most recently reported fiscal quarter, ending 2025-03-31.
| Income Statement Financials | |
-- |
|
$-3.49M |
|
-- |
|
-- |
|
$4.23M |
|
$-4.23M |
|
$0.74M |
|
$-3.49M |
|
$-3.49M |
|
$-3.49M |
|
$-3.49M |
|
$-3.49M |
|
$-3.49M |
|
$-4.23M |
|
$-4.21M |
|
3.92M |
|
3.92M |
|
$-0.89 |
|
$-0.89 |
|
| Balance Sheet Financials | |
$3.26M |
|
$0.01M |
|
$0.58M |
|
$3.84M |
|
$3.17M |
|
-- |
|
-- |
|
$3.17M |
|
$0.66M |
|
$0.66M |
|
$0.66M |
|
3.12M |
|
| Cash Flow Statement Financials | |
$-5.38M |
|
$-0.01M |
|
$7.30M |
|
$0.15M |
|
$2.06M |
|
$1.91M |
|
|
Stock-Based Compensation |
$0.06M |
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
1.03 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-5.38M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-527.15% |
|
-527.15% |
|
-91.00% |
|
-527.15% |
|
$0.21 |
|
$-1.37 |
|
$-1.37 |
|